As FXa inhibitors have been demonstrated to have anti-inflammatory effects in addition to their anticoagulant effects (Terry et al., 2016; Katoh et al., 2017), it might be assumed that this effect would reduce AF and SCD. Here, F10 is linked to Schnyder corneal dystrophy.